Global Live Attenuated Vaccines Market Insights, Forecast to 2025


Report ID : RNR-224354 Category : Pharma Healthcare Published Date : 2018
Publisher : QYResearch Pages : 97 Format : PDF
This report studies the global market size of Live Attenuated Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Live Attenuated Vaccines in these regions.

This research report categorizes the global Live Attenuated Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).

Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.

In 2017, the global Live Attenuated Vaccines market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Live Attenuated Vaccines market based on company, product type, application and key regions.

The various contributors involved in the value chain of Live Attenuated Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Live Attenuated Vaccines include

GlaxoSmithKline

Merck

Pfizer

Astellas Pharma

Johnson & Johnson

CSL

Sanofi

Serum Institute Of India

Market Size Split by Type

Bacterial

Viral

Market Size Split by Application

Hospitals

Clinics

Research Institutes

Others

Market size split by Region

North America

- United States

- Canada

- Mexico

Asia-Pacific

- China

- India

- Japan

- South Korea

- Australia

- Indonesia

- Singapore

- Malaysia

- Philippines

- Thailand

- Vietnam

Europe

- Germany

- France

- UK

- Italy

- Spain

- Russia

Central & South America

- Brazil

- Rest of Central & South America

Middle East & Africa

- GCC Countries

- Turkey

- Egypt

- South Africa

The study objectives of this report are:

To study and analyze the global Live Attenuated Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Live Attenuated Vaccines market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Live Attenuated Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Live Attenuated Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Live Attenuated Vaccines submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Live Attenuated Vaccines are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Live Attenuated Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Global Live Attenuated Vaccines Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
1.1 Live Attenuated Vaccines Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Live Attenuated Vaccines Market Size Growth Rate by Type
1.4.2 Bacterial
1.4.3 Viral
1.5 Market by Application
1.5.1 Global Live Attenuated Vaccines Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Live Attenuated Vaccines Market Size
2.1.1 Global Live Attenuated Vaccines Revenue 2016-2025
2.1.2 Global Live Attenuated Vaccines Sales 2016-2025
2.2 Live Attenuated Vaccines Growth Rate by Regions
2.2.1 Global Live Attenuated Vaccines Sales by Regions
2.2.2 Global Live Attenuated Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Live Attenuated Vaccines Sales by Manufacturers
3.1.1 Live Attenuated Vaccines Sales by Manufacturers
3.1.2 Live Attenuated Vaccines Sales Market Share by Manufacturers
3.1.3 Global Live Attenuated Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Live Attenuated Vaccines Revenue by Manufacturers
3.2.1 Live Attenuated Vaccines Revenue by Manufacturers (2016-2018)
3.2.2 Live Attenuated Vaccines Revenue Share by Manufacturers (2016-2018)
3.3 Live Attenuated Vaccines Price by Manufacturers
3.4 Live Attenuated Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Live Attenuated Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Live Attenuated Vaccines Product Category
3.4.3 Date of International Manufacturers Enter into Live Attenuated Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Live Attenuated Vaccines Sales by Type
4.2 Global Live Attenuated Vaccines Revenue by Type
4.3 Live Attenuated Vaccines Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Live Attenuated Vaccines Breakdown Data by Application
6 North America
6.1 North America Live Attenuated Vaccines by Countries
6.1.1 North America Live Attenuated Vaccines Sales by Countries
6.1.2 North America Live Attenuated Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Live Attenuated Vaccines by Type
6.3 North America Live Attenuated Vaccines by Application
6.4 North America Live Attenuated Vaccines by Company
7 Europe
7.1 Europe Live Attenuated Vaccines by Countries
7.1.1 Europe Live Attenuated Vaccines Sales by Countries
7.1.2 Europe Live Attenuated Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Live Attenuated Vaccines by Type
7.3 Europe Live Attenuated Vaccines by Application
7.4 Europe Live Attenuated Vaccines by Company
8 Asia Pacific
8.1 Asia Pacific Live Attenuated Vaccines by Countries
8.1.1 Asia Pacific Live Attenuated Vaccines Sales by Countries
8.1.2 Asia Pacific Live Attenuated Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Live Attenuated Vaccines by Type
8.3 Asia Pacific Live Attenuated Vaccines by Application
8.4 Asia Pacific Live Attenuated Vaccines by Company
9 Central & South America
9.1 Central & South America Live Attenuated Vaccines by Countries
9.1.1 Central & South America Live Attenuated Vaccines Sales by Countries
9.1.2 Central & South America Live Attenuated Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Live Attenuated Vaccines by Type
9.3 Central & South America Live Attenuated Vaccines by Application
9.4 Central & South America Live Attenuated Vaccines by Company
10 Middle East and Africa
10.1 Middle East and Africa Live Attenuated Vaccines by Countries
10.1.1 Middle East and Africa Live Attenuated Vaccines Sales by Countries
10.1.2 Middle East and Africa Live Attenuated Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Live Attenuated Vaccines by Type
10.3 Middle East and Africa Live Attenuated Vaccines by Application
10.4 Middle East and Africa Live Attenuated Vaccines by Company
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Live Attenuated Vaccines
11.1.4 Live Attenuated Vaccines Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Live Attenuated Vaccines
11.2.4 Live Attenuated Vaccines Product Description
11.2.5 Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Live Attenuated Vaccines
11.3.4 Live Attenuated Vaccines Product Description
11.3.5 Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Live Attenuated Vaccines
11.4.4 Live Attenuated Vaccines Product Description
11.4.5 Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Live Attenuated Vaccines
11.5.4 Live Attenuated Vaccines Product Description
11.5.5 Recent Development
11.6 CSL
11.6.1 CSL Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Live Attenuated Vaccines
11.6.4 Live Attenuated Vaccines Product Description
11.6.5 Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Live Attenuated Vaccines
11.7.4 Live Attenuated Vaccines Product Description
11.7.5 Recent Development
11.8 Serum Institute Of India
11.8.1 Serum Institute Of India Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Live Attenuated Vaccines
11.8.4 Live Attenuated Vaccines Product Description
11.8.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Live Attenuated Vaccines Raw Material
13.1.2 Live Attenuated Vaccines Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Live Attenuated Vaccines
Figure Global Live Attenuated Vaccines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Live Attenuated Vaccines Production Market Share by Types (Product Category) in 2017
Figure Bacterial Product Picture
Table Major Manufacturers of Bacterial
Figure Viral Product Picture
Table Major Manufacturers of Viral
Table Global Live Attenuated Vaccines Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Research Institutes
Figure Others
Figure Live Attenuated Vaccines Report Years Considered
Figure Global Live Attenuated Vaccines Market Size 2016-2025 (Million US$)
Figure Global Live Attenuated Vaccines Sales 2016-2025 (K Units)
Table Global Live Attenuated Vaccines Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Live Attenuated Vaccines Sales by Regions 2016-2025 (K Units)
Table Global Live Attenuated Vaccines Sales Market Share by Regions 2016-2025
Figure Global Live Attenuated Vaccines Sales Market Share by Regions 2016-2025
Figure 2017 Global Live Attenuated Vaccines Sales Market Share by Regions
Table Global Live Attenuated Vaccines Revenue by Regions 2016-2025 (Million US$)
Table Global Live Attenuated Vaccines Revenue Market Share by Regions 2016-2025
Figure Global Live Attenuated Vaccines Revenue Market Share by Regions 2016-2025
Figure 2017 Global Live Attenuated Vaccines Revenue Market Share by Regions
Table Global Live Attenuated Vaccines Sales by Manufacturers (2016-2018) (K Units)
Table Global Live Attenuated Vaccines Sales Share by Manufacturers (2016-2018)
Figure Global Live Attenuated Vaccines Sales Share by Manufacturers in 2017
Table Live Attenuated Vaccines Revenue by Manufacturers (2016-2018) (Million US$)
Table Live Attenuated Vaccines Revenue Share by Manufacturers (2016-2018)
Figure Live Attenuated Vaccines Value Share by Manufacturers in 2017
Table Global Live Attenuated Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Live Attenuated Vaccines Price (2016-2018) (USD/Unit)
Table Live Attenuated Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Live Attenuated Vaccines Product Category
Table Date of International Manufacturers Enter into Live Attenuated Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Live Attenuated Vaccines Sales by Type (2016-2025) (K Units)
Table Global Live Attenuated Vaccines Sales Share by Type (2016-2025)
Figure Global Live Attenuated Vaccines Sales Market Share by Type (2016-2025)
Figure Global Live Attenuated Vaccines Sales Market Share by Type in 2017
Table Global Live Attenuated Vaccines Revenue by Type (2016-2025) (Million US$)
Table Global Live Attenuated Vaccines Revenue Share by Type (2016-2025)
Figure Global Live Attenuated Vaccines Revenue Market Share by Type (2016-2025)
Figure Global Live Attenuated Vaccines Revenue Market Share by Type in 2017
Table Live Attenuated Vaccines Price by Type 2013-2018 (USD/Unit)
Table Global Live Attenuated Vaccines Sales by Application (2016-2025) (K Units)
Table Global Live Attenuated Vaccines Sales Share by Application (2016-2025)
Figure Global Sales Live Attenuated Vaccines Market Share by Application (2016-2025)
Figure Global Sales Live Attenuated Vaccines Market Share by Application (2016-2025)
Figure North America Live Attenuated Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure North America Live Attenuated Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table North America Live Attenuated Vaccines Sales by Countries (2016-2025) (K Units)
Table North America Live Attenuated Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 North America Live Attenuated Vaccines Sales Market Share by Countries
Table North America Live Attenuated Vaccines Revenue by Countries (2016-2025) (Million US$)
Table North America Live Attenuated Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Live Attenuated Vaccines Revenue Market Share by Countries
Figure United States Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure United States Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Canada Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table North America Live Attenuated Vaccines Sales by Type (2016-2025) (K Units)
Table North America Live Attenuated Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 North America Live Attenuated Vaccines Market Share by Type
Table North America Live Attenuated Vaccines Sales by Application (2016-2025) (K Units)
Table North America Live Attenuated Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 North America Live Attenuated Vaccines Market Share by Application
Table North America Live Attenuated Vaccines Sales by Company (2016-2018) (K Units)
Table North America Live Attenuated Vaccines Sales Market Share by Company (2016-2018)
Figure North America Live Attenuated Vaccines Sales Market Share by Company in 2017
Figure Europe Live Attenuated Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Europe Live Attenuated Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Live Attenuated Vaccines Sales by Countries (2016-2025) (K Units)
Table Europe Live Attenuated Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Live Attenuated Vaccines Sales Market Share by Countries
Table Europe Live Attenuated Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Europe Live Attenuated Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Live Attenuated Vaccines Revenue Market Share by Countries
Figure Germany Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Germany Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure France Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure France Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure UK Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure UK Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Italy Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Russia Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Live Attenuated Vaccines Sales by Type (2016-2025) (K Units)
Table Europe Live Attenuated Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Europe Live Attenuated Vaccines Market Share by Type
Table Europe Live Attenuated Vaccines Sales by Application (2016-2025) (K Units)
Table Europe Live Attenuated Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Europe Live Attenuated Vaccines Market Share by Application
Table Europe Live Attenuated Vaccines Sales by Company (2016-2018) (K Units)
Table Europe Live Attenuated Vaccines Sales Market Share by Company (2016-2018)
Figure Europe Live Attenuated Vaccines Sales Market Share by Company in 2017
Figure Asia Pacific Live Attenuated Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Live Attenuated Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Live Attenuated Vaccines Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Live Attenuated Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Live Attenuated Vaccines Sales Market Share by Countries
Table Asia Pacific Live Attenuated Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Live Attenuated Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Live Attenuated Vaccines Revenue Market Share by Countries
Figure China Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure China Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Japan Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Korea Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure India Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure India Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Australia Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Live Attenuated Vaccines Sales by Type (2016-2025) (K Units)
Table Asia Pacific Live Attenuated Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Live Attenuated Vaccines Market Share by Type
Table Asia Pacific Live Attenuated Vaccines Sales by Application (2016-2025) (K Units)
Table Asia Pacific Live Attenuated Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Live Attenuated Vaccines Market Share by Application
Table Asia Pacific Live Attenuated Vaccines Sales by Company (2016-2018) (K Units)
Table Asia Pacific Live Attenuated Vaccines Sales Market Share by Company (2016-2018)
Figure Asia Pacific Live Attenuated Vaccines Sales Market Share by Company in 2017
Figure Central & South America Live Attenuated Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Live Attenuated Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Live Attenuated Vaccines Sales by Countries (2016-2025) (K Units)
Table Central & South America Live Attenuated Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Live Attenuated Vaccines Sales Market Share by Countries
Table Central & South America Live Attenuated Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Live Attenuated Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Live Attenuated Vaccines Revenue Market Share by Countries
Figure Brazil Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Live Attenuated Vaccines Sales by Type (2016-2025) (K Units)
Table Central & South America Live Attenuated Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Live Attenuated Vaccines Market Share by Type
Table Central & South America Live Attenuated Vaccines Sales by Application (2016-2025) (K Units)
Table Central & South America Live Attenuated Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Live Attenuated Vaccines Market Share by Application
Table Central & South America Live Attenuated Vaccines Sales by Company (2016-2018) (K Units)
Table Central & South America Live Attenuated Vaccines Sales Market Share by Company (2016-2018)
Figure Central & South America Live Attenuated Vaccines Sales Market Share by Company in 2017
Figure Middle East and Africa Live Attenuated Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Live Attenuated Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Live Attenuated Vaccines Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Live Attenuated Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Live Attenuated Vaccines Sales Market Share by Countries
Table Middle East and Africa Live Attenuated Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Live Attenuated Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Live Attenuated Vaccines Revenue Market Share by Countries
Figure GCC Countries Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Live Attenuated Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Live Attenuated Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Live Attenuated Vaccines Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Live Attenuated Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Live Attenuated Vaccines Market Share by Type
Table Middle East and Africa Live Attenuated Vaccines Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Live Attenuated Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Live Attenuated Vaccines Market Share by Application
Table Middle East and Africa Live Attenuated Vaccines Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Live Attenuated Vaccines Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Live Attenuated Vaccines Sales Market Share by Company in 2017
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Astellas Pharma Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table CSL Company Details
Table CSL Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table CSL Recent Development
Table Sanofi Company Details
Table Sanofi Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Serum Institute Of India Company Details
Table Serum Institute Of India Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Serum Institute Of India Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Live Attenuated Vaccines Value Chain
Table Typical Suppliers of Key Live Attenuated Vaccines Raw Material
Table Live Attenuated Vaccines Customers List
Table Live Attenuated Vaccines Sales Channels
Table Live Attenuated Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources